GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Change in Acquisitions & Divestments (2024 - 2026)

GH Research (GHRS) posted quarterly Change in Acquisitions & Divestments of -$72000.0 for Q4 2025, up 99.62% year-over-year from -$36068.3 in Q4 2024, and down 118.18% quarter-over-quarter from -$33000.0 in Q3 2025.

Analysis

GH Research (GHRS) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends

GH Research's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at -$72000.0 for Q4 2025.

  • In Q4 2025, Change in Acquisitions & Divestments rose 99.62% year-over-year to -$72000.0; the TTM figure through Dec 2025 stood at $4.7 million (up 132.33% YoY), while the FY2025 annual figure was $26.7 million, down 1.75% from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 stood at -$72000.0, down from -$33000.0 in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $53.9 million in Q4 2023, with the low at -$54.0 million in Q1 2023.
  • The 4-year median for Change in Acquisitions & Divestments is -$72000.0 (2025), against an average of -$863230.8.
  • The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments soared 9560.39% in 2023, then slumped 135.25% in 2024.
  • GH Research's Change in Acquisitions & Divestments stood at $558000.0 in 2022, then jumped by 9560.39% to $53.9 million in 2023, then plunged by 135.25% to -$19.0 million in 2024, then jumped by 99.62% to -$72000.0 in 2025.
  • Business Quant data shows GHRS's Change in Acquisitions & Divestments at -$72000.0 in Q4 2025, -$33000.0 in Q3 2025, and -$82000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 GH Research 1.72 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.36 Mn
Mar 31, 2026 8.70 Mn
Dec 31, 2025 8.86 Mn
Sep 30, 2025 9.82 Mn
Jun 30, 2025 3.18 Mn
Mar 31, 2025 4.84 Mn
Dec 31, 2024 8.36 Mn
Sep 30, 2024 5.29 Mn
Jun 30, 2024 9.74 Mn
Mar 31, 2024 3.80 Mn